fbpx Product Line | Titan Spine

Product Line

Next Generation of Interbody Devices

Titan Spine offers a full line of Endoskeleton® interbody fusion devices that feature either our proprietary nanoLOCK® or our original surface technologies, which have been shown to promote a significantly greater amount of bone growth factors necessary for fusion when compared to other common interbody fusion device materials such as polyetheretherketone (PEEK) and smooth titanium.1 Our nanoLOCK® micro and nano-scaled surface features are present on all internal and external surfaces, thus providing the potential for bone growth throughout the implant.

And here are other cool things you are going to like about our implants:

  • Large windows and internal volumes provide for significant bone graft packing, desired bone graft loading, clear CT and MRI visualization, and the potential for multi-directional bone growth.
  • Endplate sparing design (no ridges or teeth) does not damage the vertebral endplate, thus yielding increased resistance to subsidence.
  • Large footprints allow the implants to reside on the apophyseal ring, which further resists subsidence.
  • Radiopaque nature of titanium assists in placing the device in the desired location.
  • Large variety of sizes accommodate various patient anatomies.
  1. Olivares-Navarrete, R., Gittens, R.A., Schneider, J.M., Hyzy, S.L., Haithcock, D.A., Ullrich, P.F., Schwartz, Z., Boyan, B.D. (2012). Osteoblasts exhibit a more differentiated phenotype and increased bone morphogenetic production on titanium alloy substrates than poly-ether-ether-ketone. The Spine Journal, 12, 265-272.

PRODUCT PORTFOLIO

We offer a wide range of implant designs for all common anterior, posterior, and lateral approaches to the cervical and lumbar spine.

Endoskeleton® TL Endoskeleton® TL: Lumbar interbody device for lateral lumbar interbody fusion (LLIF) procedures.
  • Lateral fusion device for the lumbar spine
  • Proximal/Inserter window allows for post-implantation bone graft packing
  • Smooth and tapered leading edge permits easy insertion while maximizing surface technology/bone contact once seated
  • Center strut aids in accurate placement using intraoperative fluoroscopy
  • Heights in 1mm increments enable precise anatomical fit
  • Available in fifty-six different sizes to accommodate various patient anatomies

The Endoskeleton® TL device is indicated for use in spinal fusion procedures in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. Patients should have received 6 months of non-operative treatment prior to treatment with the devices. This device is intended for use with supplemental fixation systems cleared for use in the lumbar spine. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). Patients with non-fusion spinal surgery at the involved level(s) may be treated with the device. It is indicated to be used with autograft bone. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TL
download specs sheet
Endoskeleton® TAS Lumbar interbody device with integrated screws for anterior lumbar interbody fusion (ALIF) procedures.
  • ALIF cage option for cases that require additional fixation without the need for supplemental posterior instrumentation
  • Features three integrated grit-blasted screws for immediate mechanical stability; allow for up to 10° of medial/lateral or anterior/posterior angular variation
  • Unique texture of both cage and screw surfaces helps secure device in place upon implantation and helps to prevent screw back-out
  • Available in thirty-six sizes for increased surgeon choice and improved anatomical fit

The Endoskeleton® TAS device is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). Patients should have received 6 months of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TAS is indicated to be used with autograft bone. The device is a standalone system intended to be used with the bone screws provided and requires no additional supplementary fixation. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TAS
download specs sheet
Endoskeleton® TA Lumbar interbody device for anterior lumbar interbody fusion (ALIF) procedures.
  • Anterior window allows for additional bone graft packing after implantation
  • Indicated to be used with or without supplemental posterior instrumentation

The Endoskeleton® TA device is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). Patients should have received 6 months of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TA is indicated to be used with autograft bone and may be used with supplemental fixation. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TA
download specs sheet
Endoskeleton® TT Lumbar interbody device for transforaminal lumbar interbody fusion (TLIF) procedures.
  • Smooth leading nose and edges allow for easy insertion
  • Available in fourteen different sizes to accommodate various patient anatomies

The Endoskeleton® TT device is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). Patients should have received 6 months of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TT is indicated to be used with supplemental fixation and autograft bone. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TT
download specs sheet
Endoskeleton® TO Lumbar interbody device for posterior lumbar interbody fusion (PLIF) and oblique procedures.
  • Smooth leading nose and edges allow for easy insertion
  • Available in twenty-five different sizes to accommodate various patient anatomies

The Endoskeleton® TO device is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). Patients should have received 6 months of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TO is indicated to be used with supplemental fixation and autograft bone. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TO
download specs sheet
Endoskeleton® TCS Cervical interbody device with integrated screws for anterior discectomy and fusion (ACDF) procedures.
  • Cervical cage with integrated fixation
  • Features two grit-blasted integrated anti-backout or standard screws for immediate mechanical stability
  • Integrated collar prevents screw backout
  • Screws act independently from the implant to allow for variable angle screw placement
  • Zero-profile design prevents disruption to adjacent anatomical structures
  • Available in a variety sizes to accommodate various patient anatomies

The Endoskeleton® TCS is indicated for use for anterior cervical interbody fusion in skeletally mature patients with Degenerative Disc Disease (DDD) of the cervical spine at one disc level from C-2 to T-1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have received 6 weeks of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TCS is indicated to be used with autograft bone. The device is a standalone system when used with Endoskeleton® TCS integrated screws, and when used without the integrated screws, it requires additional supplemental fixation cleared in the cervical spine. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TCS
download specs sheet
Endoskeleton® TC Cervical interbody device for anterior cervical discectomy and fusion (ACDF) procedures.
  • Anterior window allows for additional bone graft packing after implantation

The Endoskeleton® TC is indicated for use for anterior cervical interbody fusion in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine at one disc level from C-3 to C-7. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have received 6 weeks of non-operative treatment prior to surgical treatment with the device. The Endoskeleton® TC is indicated to be used with supplemental fixation and autograft bone. This implant may be covered by one or more patents and pending patent applications. For details, please visit our Intellectual Property page.
Endoskeleton® TC
download specs sheet
Titan Spine's Endoskeleton® Device Warranty

Titan Spine's Endoskeleton® Device Warranty

read more
Basic Science Research & Clinical Outcomes

Basic Science Research & Clinical Outcomes

read more
Titan Spine Conferences and Events

Titan Spine Conferences and Events

read more

Press Releases

Titan Spine Appoints Peter Wehrly to Board of Directors

Titan Spine Appoints Peter Wehrly to Board of Directors

read more
Titan Spine Appoints Brian Burke as Chief Operating Officer

Titan Spine Appoints Brian Burke as Chief Operating Officer

read more
Back Pain Centers of America Launches Free E-Book for Patients Considering Back Surgery

Back Pain Centers of America Launches Free E-Book for Patients Considering Back Surgery

read more
Titan Spine Announces New Memphis Distribution Center to Meet Growing Demand for nanoLOCK® Spinal Implants

Titan Spine Announces New Memphis Distribution Center to Meet Growing Demand for nanoLOCK® Spinal Implants

read more
Titan Spine® Announces Review of Research Supporting its nanoLOCK® Titanium Spinal Implants Published in SPINE

Titan Spine® Announces Review of Research Supporting its nanoLOCK® Titanium Spinal Implants Published in SPINE

read more